Advisors Asset Management, Inc. Global Blood Therapeutics, Inc. Transaction History

Advisors Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$22.3 - $37.39 $44,354 - $74,368	-1,989 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$25.68 - $35.59 $10,477 - $14,520	-408 Reduced 17.02%	1,989 $69,000
Q4 2021 Feb 15, 2022	SELL	$24.9 - $40.26 $547 - $885	-22 Reduced 0.91%	2,397 $70,000
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $50 - $74	-2 Reduced 0.08%	2,419 $62,000
Q2 2021 Jul 30, 2021	SELL	$32.46 - $43.42 $292 - $390	-9 Reduced 0.37%	2,421 $85,000
Q1 2021 May 07, 2021	SELL	$38.94 - $50.85 $2,375 - $3,101	-61 Reduced 2.45%	2,430 $99,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $6,852 - $11,606	182 Added 7.88%	2,491 $108,000
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $56,453 - $79,704	1,070 Added 86.36%	2,309 $127,000
Q2 2020 Aug 12, 2020	BUY	$48.73 - $81.82 $60,376 - $101,374	1,239 New	1,239 $78,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.